Benzinga's Top #PreMarket Losers
December 28, 2015 at 08:28 AM EST
Chimerix Inc (NASDAQ: CMRX) shares dipped 74.70 percent to $9.00 following Phase 3 trial failure. Chimerix announced in a press ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.